Across TCGA pan-cancer cohorts, TAF9BP2 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of TAF9BP2’s most consistent transcriptional readouts.
The strongest signal is observed in thyroid carcinoma (THCA), where TAF9BP2 RNA is repressed in tumor relative to normal tissue. In most cancer types TAF9BP2 is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.
THCA are the cancer types where TAF9BP2 tumor–normal differential expression is most reproducible.